|
1
|
Cross M, Smith E, Hoy D, et al: The global
burden of hip and knee osteoarthritis: estimates from the global
burden of disease 2010 study. Ann Rheum Dis. 3:1323–1330. 2014.
View Article : Google Scholar
|
|
2
|
Kronenberg HM: Developmental regulation of
the growth plate. Nature. 423:332–336. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Emons J, Chagin AS, Sävendahl L, Karperien
M and Wit JM: Mechanisms of growth plate maturation and epiphyseal
fusion. Hormone Res Paediatr. 75:383–391. 2011. View Article : Google Scholar
|
|
4
|
Negishi Y, Ui N, Nakajima M, et al:
p21Cip-1/SDI-1/WAF-1 gene is involved in chondrogenic
differentiation of ATDC5 cells in vitro. J Biol Chem.
276:33249–33256. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schmid TM and Linsenmayer TF:
Immunohistochemical localization of short chain cartilage collagen
(type X) in avian tissues. J Cell Biol. 100:598–605. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nakayama K and Nakayama K: Cip/Kip
cyclin-dependent kinase inhibitors: brakes of the cell cycle engine
during development. BioEssays. 20:1020–1029. 1998. View Article : Google Scholar
|
|
7
|
Sherr CJ and Roberts JM: CDK inhibitors:
positive and negative regulators of G1-phase progression. Genes
Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He G, Siddik ZH, Huang Z, et al: Induction
of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2
activities. Oncogene. 24:2929–2943. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seoane J, Le HV and Massagué J: Myc
suppression of the p21(Cip1) Cdk inhibitor influences the outcome
of the p53 response to DNA damage. Nature. 419:729–734. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Harper JW, Adami GR, Wei N, Keyomarsi K
and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent
inhibitor of G1 cyclin-dependent kinases. Cell. 75:805–816. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Asada M, Yamada T, Ichijo H, et al:
Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in
monocytic differentiation. EMBO J. 18:1223–1234. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Olive M, Mellad JA, Beltran LE, et al:
p21Cip1 modulates arterial wound repair through the
stromal cell-derived factor-1/CXCR4 axis in mice. J Clin Invest.
118:2050–2061. 2008.PubMed/NCBI
|
|
13
|
Gartel AL and Radhakrishnan SK: Lost in
transcription: p21 repression, mechanisms, and consequences. Cancer
Res. 65:3980–3985. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hong H, Takahashi K, Ichisaka T, et al:
Suppression of induced pluripotent stem cell generation by the
p53-p21 pathway. Nature. 460:1132–1135. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kawamura T, Suzuki J, Wang YV, et al:
Linking the p53 tumour suppressor pathway to somatic cell
reprogramming. Nature. 460:1140–1144. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bedelbaeva K, Snyder A, Gourevitch D, et
al: Lack of p21 expression links cell cycle control and appendage
regeneration in mice. Proc Natl Acad Sci USA. 107:5845–5850. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aikawa T, Segre GV and Lee K: Fibroblast
growth factor inhibits chondrocytic growth through induction of p21
and subsequent inactivation of cyclin E-Cdk2. J Biol Chem.
276:29347–29352. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakajima M, Negishi Y, Tanaka H and
Kawashima K: p21(Cip-1/SDI-1/WAF-1) expression via the
mitogen-activated protein kinase signaling pathway in
insulin-induced chondrogenic differentiation of ATDC5 cells.
Biochem Biophys Res Commun. 320:1069–1075. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deng C, Zhang P, Harper JW, Elledge SJ and
Leder P: Mice lacking p21CIP1/WAF1 undergo normal
development, but are defective in G1 checkpoint control. Cell.
82:675–684. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baldin V, Lukas J, Marcote MJ, Pagano M
and Draetta G: Cyclin D1 is a nuclear protein required for cell
cycle progression in G1. Genes Dev. 7:812–821. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Byeon IJ, Li J, Ericson K, et al: Tumor
suppressor p16INK4A: determination of solution structure
and analyses of its interaction with cyclin-dependent kinase 4. Mol
Cell. 1:421–431. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bi W, Deng JM, Zhang Z, Behringer RR and
de Crombrugghe B: Sox9 is required for cartilage formation. Nat
Genet. 22:85–89. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Niculescu AB III, Chen X, Smeets M, Hengst
L, Prives C and Reed SI: Effects of p21(Cip1/Waf1) at both the G1/S
and the G2/M cell cycle transitions: pRb is a critical determinant
in blocking DNA replication and in preventing endoreduplication.
Mol Cell Biol. 18:629–643. 1998.PubMed/NCBI
|
|
24
|
Gratzner HG: Monoclonal antibody to
5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA
replication. Science. 218:474–475. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cánepa ET, Scassa ME, Ceruti JM, et al:
INK4 proteins, a family of mammalian CDK inhibitors with novel
biological functions. IUBMB Life. 59:419–426. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sherr CJ: G1 phase progression: cycling on
cue. Cell. 79:551–555. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
LaBaer J, Garrett MD, Stevenson LF, et al:
New functional activities for the p21 family of CDK inhibitors.
Genes Dev. 11:847–862. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kiyokawa H, Kineman RD, Manova-Todorova
KO, et al: Enhanced growth of mice lacking the cyclin-dependent
kinase inhibitor function of p27(Kip1). Cell. 85:721–732. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Emons JA, Marino R, Nilsson O, et al: The
role of p27Kip1 in the regulation of growth plate
chondrocyte proliferation in mice. Pediatr Res. 60:288–293. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Macleod KF, Sherry N, Hannon G, et al:
p53-dependent and independent expression of p21 during cell growth,
differentiation, and DNA damage. Genes Dev. 9:935–944. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Parker SB, Eichele G, Zhang P, et al:
p53-independent expression of p21Cip1 in muscle and
other terminally differentiating cells. Science. 267:1024–1027.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stewart MC, Farnum CE and MacLeod JN:
Expression of p21CIP1/WAF1 in chondrocytes. Calcif
Tissue Int. 61:199–204. 1997. View Article : Google Scholar : PubMed/NCBI
|
